FDA Inspection 1267621 — LaBudde Group, Inc
The FDA completed an inspection of LaBudde Group, Inc on April 17, 2025 in Cedarburg, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Cedarburg, WI (United States)
Additional Details
FSVP